TP53-altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single

Rory M Shallis1, Naval G Daver2, Jessica K Altman3

  • 1Section of Hematology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.

Cancer
|November 18, 2022
PubMed